Exact Sciences Corporation (EXAS)

Exact Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	605.38	242.49	315.47	1,491	177.25
Short-Term Investments	172.27	389.56	715.01	348.7	146.4
Cash & Cash Equivalents	777.64	632.06	1,030	1,840	323.66
Cash Growth	23.03%	-38.66%	-44.00%	468.50%	-71.21%
Receivables	203.62	158.04	216.65	233.19	130.36
Inventory	127.48	118.26	104.99	92.27	61.72
Other Current Assets	85.63	73.9	74.12	33.16	38.2
Total Current Assets	1,194	982.26	1,426	2,199	553.94
Property, Plant & Equipment	842.06	851.76	754.47	577.93	581.77
Goodwill and Intangibles	4,258	4,302	4,430	2,085	2,347
Other Long-Term Assets	177.39	90.58	74.59	63.77	23.32
Total Long-Term Assets	5,277	5,245	5,259	2,726	2,952
Total Assets	6,471	6,227	6,685	4,925	3,506
Accounts Payable	78.82	74.92	67.83	35.71	25.97
Current Debt	79.38	28.37	19.71	325.52	8.73
Other Current Liabilities	356.51	309.47	429.53	271.87	201.8
Total Current Liabilities	514.7	412.75	517.07	633.1	236.49
Long-Term Debt	2,475	2,419	2,362	2,005	946.3
Other Long-Term Liabilities	335.98	352.46	417.78	51.34	34.91
Total Long-Term Liabilities	2,811	2,771	2,780	2,056	981.21
Total Liabilities	3,326	3,184	3,297	2,690	1,218
Total Debt	2,555	2,447	2,382	2,331	955.03
Debt Growth	4.41%	2.72%	2.21%	144.04%	38.56%
Retained Earnings	-3,469.18	-3,265.03	-2,641.52	-2,045.9	-1,119.76
Comprehensive Income	1.43	-5.24	-1.44	0.53	-0.1
Shareholders' Equity	3,145	3,043	3,388	2,236	2,288
Net Cash / Debt	-1,777.08	-1,814.81	-1,351.63	-490.63	-631.37
Net Cash Per Share	-9.86	-10.29	-7.89	-3.25	-4.81
Working Capital	679.67	569.51	909.17	1,565	317.44
Book Value Per Share	17.46	17.26	19.77	14.79	17.43

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).